Skip to main content
Fig. 2 | Lipids in Health and Disease

Fig. 2

From: Effect of ezetimibe add-on therapy over 52 weeks extension analysis of prospective randomized trial (RESEARCH study) in type 2 diabetes subjects

Fig. 2

The changes in LDL cholesterol. a The percentage reduction from baseline in LDL-C after 52 weeks of treatment: Blue bar represents percent change in DST and orange bar represents percent change in EST. Error bars represent standard deviations. The p-value indicates statistically significant difference between groups by Wilcoxon tests. b Achievement rates in each treatment group. The bars of DST group are moss green, and EAT group red. The p-value indicates statistically significant difference between groups by a chi-square test

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X